Exelixis Inc
EXEL •
Buy Open
Signal type
Buy
Status
Open
Open Price
$44.19
Stop Loss
$42.33
Performance
3.79%
Days Open
14
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 1, 2026
Open Price $44.19
Stop Loss $42.33
Timespan Day
Company Profile
Name Exelixis Inc
Ticker EXEL
Market Cap $12.02B
Sector BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Latest Close $45.86
List Date Apr 11, 2000
Description
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Website Open Company Website